ATE431739T1 - Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid - Google Patents
Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochloridInfo
- Publication number
- ATE431739T1 ATE431739T1 AT03741747T AT03741747T ATE431739T1 AT E431739 T1 ATE431739 T1 AT E431739T1 AT 03741747 T AT03741747 T AT 03741747T AT 03741747 T AT03741747 T AT 03741747T AT E431739 T1 ATE431739 T1 AT E431739T1
- Authority
- AT
- Austria
- Prior art keywords
- amorphous form
- pharmaceutical composition
- donepezil hydrochloride
- composition containing
- containing stabilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200200155A SI21223A (sl) | 2002-06-19 | 2002-06-19 | Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom |
PCT/SI2003/000019 WO2004000317A1 (en) | 2002-06-19 | 2003-06-18 | Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE431739T1 true ATE431739T1 (de) | 2009-06-15 |
Family
ID=29778199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03741747T ATE431739T1 (de) | 2002-06-19 | 2003-06-18 | Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1513528B1 (de) |
AT (1) | ATE431739T1 (de) |
AU (1) | AU2003279102A1 (de) |
CY (1) | CY1109314T1 (de) |
DE (1) | DE60327696D1 (de) |
DK (1) | DK1513528T3 (de) |
EA (1) | EA012904B1 (de) |
ES (1) | ES2326529T3 (de) |
HR (1) | HRP20041198B1 (de) |
PL (1) | PL212584B1 (de) |
PT (1) | PT1513528E (de) |
RS (1) | RS51824B (de) |
SI (2) | SI21223A (de) |
UA (1) | UA86573C2 (de) |
WO (1) | WO2004000317A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL150509A (en) | 2002-07-01 | 2007-07-04 | Joseph Kaspi | Pharmaceutical preparations containing donafazil hydrochloride |
IL154370A0 (en) * | 2003-02-10 | 2003-09-17 | Chemagis Ltd | Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same |
EP1776089A2 (de) * | 2003-12-31 | 2007-04-25 | Actavis Group hf | Donepezil-formulierungen |
US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
EP1579862A1 (de) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern |
WO2006035433A2 (en) | 2004-09-29 | 2006-04-06 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
UA83152C2 (ru) * | 2004-10-19 | 2008-06-10 | Крка, Товарна Здравіл, Д.Д., Ново Мєсто | Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид |
WO2006063025A1 (en) * | 2004-12-07 | 2006-06-15 | Nektar Therapeutics | Stable non-crystalline formulation comprising donepezil |
US20060122226A1 (en) | 2004-12-08 | 2006-06-08 | Itai Adin | Crystalline forms of Donepezil base |
EP1830886B1 (de) | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Verfahren zur stabilisierung eines arzneimittels gegen demenz |
JP2007015934A (ja) * | 2005-07-05 | 2007-01-25 | Meiko Shoji Kk | 温感クリーム化粧料 |
DE102005060377A1 (de) * | 2005-12-16 | 2007-06-21 | Ratiopharm Gmbh | Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung |
EP1920785A1 (de) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat |
DE102007037932A1 (de) | 2007-08-11 | 2009-02-12 | Alfred E. Tiefenbacher Gmbh & Co.Kg | Donepezilhydrochlorid in amorpher Form enthaltende Tablette |
DE102009041839A1 (de) * | 2009-09-18 | 2011-03-24 | Dolorgiet Gmbh & Co. Kg | Donepezil-haltige Tabletten |
EP2366378A1 (de) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Donepezilformulierungen mit verzögerter Freisetzung |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
EP2502620A1 (de) | 2011-03-24 | 2012-09-26 | Krka Tovarna Zdravil, D.D., Novo Mesto | Feste pharmazeutische Zusammensetzung mit Donepezil |
US10398705B2 (en) | 2012-03-15 | 2019-09-03 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
WO2015007760A1 (en) | 2013-07-19 | 2015-01-22 | Boehringer Ingelheim Vetmedica Gmbh | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
CN110721164A (zh) | 2013-12-04 | 2020-01-24 | 勃林格殷格翰动物保健有限公司 | 匹莫苯的改善的药物组合物 |
US20180344646A1 (en) * | 2015-11-25 | 2018-12-06 | Patheon Development Services Inc. | Amorphous dispersion granules and oral dosage forms |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
KR102372630B1 (ko) * | 2019-05-15 | 2022-03-14 | 주식회사 대웅제약 | 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2525108B1 (fr) * | 1982-04-19 | 1989-05-12 | Elan Corp Ltd | Medicaments a haut degre de solubilite et procede pour leur obtention |
SI9720038B (sl) * | 1996-06-07 | 2010-06-30 | Eisai Co Ltd | Polimorfi donepezil hidroklorida in postopek izdelave |
ES2310164T3 (es) * | 1999-02-10 | 2009-01-01 | Pfizer Products Inc. | Dispositivo de liberacion controlada por la matriz. |
EP1175205B1 (de) * | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
-
2002
- 2002-06-19 SI SI200200155A patent/SI21223A/sl not_active IP Right Cessation
-
2003
- 2003-06-18 EP EP03741747A patent/EP1513528B1/de not_active Expired - Lifetime
- 2003-06-18 PL PL372116A patent/PL212584B1/pl unknown
- 2003-06-18 AT AT03741747T patent/ATE431739T1/de active
- 2003-06-18 PT PT03741747T patent/PT1513528E/pt unknown
- 2003-06-18 WO PCT/SI2003/000019 patent/WO2004000317A1/en not_active Application Discontinuation
- 2003-06-18 AU AU2003279102A patent/AU2003279102A1/en not_active Abandoned
- 2003-06-18 DE DE60327696T patent/DE60327696D1/de not_active Expired - Lifetime
- 2003-06-18 ES ES03741747T patent/ES2326529T3/es not_active Expired - Lifetime
- 2003-06-18 DK DK03741747T patent/DK1513528T3/da active
- 2003-06-18 EA EA200500040A patent/EA012904B1/ru not_active IP Right Cessation
- 2003-06-18 RS YU110604A patent/RS51824B/en unknown
- 2003-06-18 SI SI200331643T patent/SI1513528T1/sl unknown
- 2003-06-18 UA UAA200500514A patent/UA86573C2/ru unknown
-
2004
- 2004-12-17 HR HRP20041198AA patent/HRP20041198B1/hr not_active IP Right Cessation
-
2009
- 2009-08-17 CY CY20091100878T patent/CY1109314T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003279102A1 (en) | 2004-01-06 |
CY1109314T1 (el) | 2014-07-02 |
WO2004000317A1 (en) | 2003-12-31 |
RS51824B (en) | 2012-02-29 |
PT1513528E (pt) | 2009-08-18 |
EA200500040A1 (ru) | 2005-06-30 |
ES2326529T3 (es) | 2009-10-14 |
PL372116A1 (en) | 2005-07-11 |
HRP20041198A2 (en) | 2005-04-30 |
RS110604A (en) | 2007-02-05 |
SI21223A (sl) | 2003-12-31 |
UA86573C2 (ru) | 2009-05-12 |
HRP20041198B1 (hr) | 2013-05-31 |
DK1513528T3 (da) | 2009-09-07 |
EP1513528B1 (de) | 2009-05-20 |
EA012904B1 (ru) | 2010-02-26 |
SI1513528T1 (sl) | 2009-10-31 |
EP1513528A1 (de) | 2005-03-16 |
PL212584B1 (pl) | 2012-10-31 |
DE60327696D1 (de) | 2009-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109314T1 (el) | Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης | |
RU2424240C2 (ru) | Антибактериальные производные пиперидина | |
DE69733478D1 (de) | Ether-muskarinantagonisten | |
JP2003506406A5 (de) | ||
NO20055568L (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
BR9408351A (pt) | Composto composição farmacêutica processos para antagonizar o efeito de substância p e de neuroquinina a no seu sitio receptor processos para tratamento ou prevenção de dor ou nocipecção asma fibrose cistica emese e processo para a preparação de um composto | |
RU2000129161A (ru) | Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт | |
DK0788481T3 (da) | Fremgangsmåde til fremstilling af levobupivacain og analoger deraf | |
NO20051871L (no) | Opioidreseptorantagonister | |
NO20062004L (no) | Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav | |
CA2432578A1 (en) | Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists | |
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
UA84146C2 (ru) | Амиды пирролопиридин-2-карбоновой кислоты как ингибиторы гликогенфосфорилазы, способ их получения, фармацевтическая композиция и их применение как терапевтических агентов для лечения заболеваний | |
NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
HU211622A9 (en) | Piperidine derivatives | |
NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
KR19990028807A (ko) | 디페닐메틸렌 피페리딘 유도체 | |
ATE403426T1 (de) | Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen | |
EA200700150A1 (ru) | Новая фармацевтическая соль 1-бензил-4-[(5,6-диметокси-1-инданон)-2-ил] метилпиперидина (донепезил) | |
NZ543068A (en) | Substituted 4-(alkyl-amide)-piperidine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
DE60220953D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon | |
PL375163A1 (en) | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
CY1106900T1 (el) | Χρηση παραγωγων πυριδιν-2-υλμεθυλαμινης για τη θεραπεια συμπτωματων χρονιου πονου νευροπαθους ή ψυχογενους προελευσης | |
HUP0202972A2 (hu) | Vazopresszin antagonista készítmény és eljárás az előállítására | |
HUP0204297A2 (hu) | (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1513528 Country of ref document: EP |